UK Prostate Cancer Diagnostic and Therapeutic Market Share & Forecast To 2025Posted by Rishabh on March 17th, 2020 UK prostate cancer market is forecast to grow at a CAGR of 9.7% during the forecast period. The high incidence of prostate cancer is the major factor for augmenting the demand for prostate cancer diagnostics services and therapeutics in the country. As per the World Health Organization, around 56,000 new cases of prostate cancer were registered in 2018. It is the most common cancer in the country with around 24% of the overall new cancer cases in men. The 5-year prevalence in the country due to prostate cancer is around 206,000 in 2018. Request a Free Sample of Our Report on UK Prostate Cancer Diagnostic and Therapeutic Market: https://www.omrglobal.com/request-sample/uk-prostate-cancer-diagnostic-therapeutic-market In UK, prostate cancer is the second largest cause of cancer mortalities with around 13,000 mortalities in 2018. This is primarily due to the increasing aging population of UK. As per Cancer Research UK, more than half (54%) of prostate cancer cases in the UK each year are diagnosed in males aged 70 and over of age. Moreover, incidence rates for prostate cancer are projected to rise by 12% in the UK between 2014 and 2035 and 1 in 8 men will be diagnosed with prostate cancer during their lifetime in the country. Prostate cancer is most common in black males, then White males and least common in Asian males. A Full Report of UK Prostate Cancer Diagnostic and Therapeutic Market is Available at: https://www.omrglobal.com/industry-reports/uk-prostate-cancer-diagnostic-therapeutic-market UK prostate cancer diagnostic and therapeutics market has been studied on the basis of diagnostic techniques and therapeutics. By diagnosis technique, prostate biopsy is expected to hold a major market share during the forecast period. By therapeutics, chemotherapy is expected to have a major market share in the country. The companies which are contributing significantly in the market include Abbott Laboratories, AbbVie Products, LLC, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Siemens Healthcare AG, and others. Secondary Sources Include
Market Segmentation UK Prostate Cancer Market by Diagnostic Techniques
UK Prostate Cancer Market by Therapeutics
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Like it? Share it! More by this author |